share_log

Viracta Therapeutics | 8-K: Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

SEC ·  Nov 13 20:33
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.